2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Greenman William Mariner | CEO | 4,115,845 | Mar 17, 2025 |
| Jayaraman Vivek K | COO | 1,431,326 | Mar 17, 2025 |
| Green Kevin Dennis | CFO | 875,867 | Mar 17, 2025 |
| Jensen Chrystal | Chief Legal Officer | 728,294 | Nov 26, 2025 |
| Benjamin Richard J | Chief Medical Officer | 685,775 | Mar 17, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4, 2026 | Benjamin Richard J | Chief Medical Officer | Neutral | 90.0 | +264,000 | 38.50% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Green Kevin Dennis | CFO | Neutral | 90.0 | +300,000 | 33.81% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Greenman William Mariner | CEO | Neutral | 90.0 | +1,200,000 | 29.05% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Jayaraman Vivek K | COO | Neutral | 90.0 | +420,000 | 29.03% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Jensen Chrystal | Chief Legal Officer | Neutral | 90.0 | +300,000 | 41.19% | ✗ | - |
| Nov 24, 2025 | Nov 26, 2025 | Jensen Chrystal | Chief Legal Officer | Sell | 22.5 | -55,000 | -7.02% | ✗ | $93.5K |
| Aug 25, 2025 | Aug 25, 2025 | Gregory Dean A. | Director | Buy | 91.3 | +25,000 | 40.50% | ✗ | $31.3K |
| Jun 3, 2025 | Jun 4, 2025 | Witney Frank | Director | Neutral | 90.0 | +60,000 | 27.27% | ✗ | - |
| Jun 3, 2025 | Jun 4, 2025 | MOORE TIMOTHY L. | Director | Neutral | 90.0 | +60,000 | 41.36% | ✗ | - |
| Jun 3, 2025 | Jun 4, 2025 | Swisher Daniel N JR | Director | Neutral | 90.0 | +60,000 | 40.80% | ✗ | - |
| Jun 3, 2025 | Jun 4, 2025 | NACHTSHEIM JAMI K | Director | Neutral | 90.0 | +60,000 | 40.44% | ✗ | - |
| Jun 3, 2025 | Jun 4, 2025 | Lucena Ann | Director | Neutral | 90.0 | +60,000 | 53.44% | ✗ | - |
| Jun 3, 2025 | Jun 4, 2025 | Shan Hua | Director | Neutral | 90.0 | +60,000 | 82.89% | ✗ | - |
| Jun 3, 2025 | Jun 4, 2025 | BJERKHOLT ERIC | Director | Neutral | 90.0 | +60,000 | 37.01% | ✗ | - |
| Mar 13, 2025 | Mar 17, 2025 | Jensen Chrystal | Chief Legal Officer | Sell | 32.5 | -49,024 | -5.89% | ✓ | $71.1K |
| Mar 13, 2025 | Mar 17, 2025 | Jayaraman Vivek K | COO | Sell | 32.5 | -75,989 | -5.04% | ✓ | $110.2K |
| Mar 13, 2025 | Mar 17, 2025 | Greenman William Mariner | CEO | Sell | 35.0 | -193,913 | -4.50% | ✓ | $281.2K |
| Mar 13, 2025 | Mar 17, 2025 | Green Kevin Dennis | CFO | Sell | 32.5 | -59,887 | -6.40% | ✓ | $86.8K |
| Mar 13, 2025 | Mar 17, 2025 | Benjamin Richard J | Chief Medical Officer | Sell | 32.5 | -49,024 | -6.67% | ✓ | $71.1K |
| Mar 6, 2025 | Mar 10, 2025 | Jensen Chrystal | Chief Legal Officer | Sell | 91.3 | +427,120 | 105.41% | ✓ | $41.1K |
| Mar 6, 2025 | Mar 10, 2025 | Jayaraman Vivek K | COO | Sell | 95.0 | +601,487 | 66.40% | ✓ | $50.9K |
| Mar 6, 2025 | Mar 10, 2025 | Greenman William Mariner | CEO | Sell | 95.0 | +1,079,758 | 33.43% | ✓ | $91.4K |
| Mar 6, 2025 | Mar 10, 2025 | Green Kevin Dennis | CFO | Sell | 91.3 | +441,892 | 89.48% | ✓ | $46.7K |
| Mar 6, 2025 | Mar 10, 2025 | Benjamin Richard J | Chief Medical Officer | Sell | 91.3 | +340,426 | 86.32% | ✓ | $39.2K |
| Mar 3, 2025 | Mar 5, 2025 | Jensen Chrystal | Chief Legal Officer | Sell | 25.0 | -66,292 | -14.06% | ✓ | $104.9K |
| Mar 3, 2025 | Mar 5, 2025 | Jayaraman Vivek K | COO | Sell | 48.8 | -10,780 | -1.18% | ✓ | $16.7K |
| Mar 3, 2025 | Mar 5, 2025 | Greenman William Mariner | CEO | Sell | 51.3 | -23,023 | -0.71% | ✓ | $35.7K |
| Mar 3, 2025 | Mar 5, 2025 | Green Kevin Dennis | CFO | Sell | 32.5 | -69,042 | -6.18% | ✓ | $108.7K |
| Mar 3, 2025 | Mar 5, 2025 | Benjamin Richard J | Chief Medical Officer | Sell | 25.0 | -57,546 | -12.73% | ✓ | $90.6K |
| Feb 26, 2025 | Feb 28, 2025 | Jensen Chrystal | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2025 | Feb 28, 2025 | Jayaraman Vivek K | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2025 | Feb 28, 2025 | Greenman William Mariner | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2025 | Feb 28, 2025 | Green Kevin Dennis | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2025 | Feb 28, 2025 | Benjamin Richard J | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 13, 2024 | Jan 2, 2025 | Gregory Dean A. | Director | Buy | 82.5 | +1,725 | 2.88% | ✗ | $2.9K |
| Dec 12, 2024 | Dec 16, 2024 | BJERKHOLT ERIC | Director | Sell | 26.3 | -20,000 | -10.98% | ✗ | $35.7K |
| Dec 16, 2024 | Dec 16, 2024 | Jensen Chrystal | Chief Legal Officer | Sell | 41.3 | -16,667 | -3.51% | ✓ | $28.5K |
| Sep 3, 2024 | Sep 5, 2024 | Green Kevin Dennis | CFO | Sell | 25.0 | -82,657 | -13.36% | ✓ | $178.7K |
| Aug 15, 2024 | Aug 19, 2024 | Jensen Chrystal | Chief Legal Officer | Sell | 41.3 | -16,667 | -3.40% | ✓ | $34.4K |
| Aug 2, 2024 | Aug 7, 2024 | Benjamin Richard J | Chief Medical Officer | Sell | 37.5 | -21,605 | -4.70% | ✓ | $54K |
| Jul 1, 2024 | Jul 2, 2024 | Gregory Dean A. | Director | Neutral | 90.0 | +60,000 | 100.00% | ✗ | - |
| Jul 2, 2024 | Gregory Dean A. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 5, 2024 | Jun 6, 2024 | Witney Frank | Director | Neutral | 90.0 | +40,000 | 22.21% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | Swisher Daniel N JR | Director | Neutral | 90.0 | +40,000 | 37.37% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | Shan Hua | Director | Neutral | 90.0 | +40,000 | 123.51% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | SCHULZE GAIL | Director | Neutral | 90.0 | +40,000 | 32.41% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | NACHTSHEIM JAMI K | Director | Neutral | 90.0 | +40,000 | 36.91% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | MOORE TIMOTHY L. | Director | Neutral | 90.0 | +40,000 | 38.07% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | Lucena Ann | Director | Neutral | 90.0 | +40,000 | 55.34% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | BJERKHOLT ERIC | Director | Neutral | 90.0 | +40,000 | 28.14% | ✗ | - |
| May 13, 2024 | May 14, 2024 | Shan Hua | Director | Buy | 85.0 | +2,500 | 8.37% | ✗ | $5K |
| May 10, 2024 | May 13, 2024 | NACHTSHEIM JAMI K | Director | Buy | 77.5 | +2,000 | 1.88% | ✗ | $3.6K |
| May 9, 2024 | May 10, 2024 | Witney Frank | Director | Buy | 91.3 | +20,000 | 12.50% | ✗ | $37.8K |
| May 9, 2024 | May 9, 2024 | Swisher Daniel N JR | Director | Buy | 77.5 | +2,500 | 2.39% | ✗ | $4.7K |
| Mar 12, 2024 | Mar 14, 2024 | Green Kevin Dennis | CFO | Sell | 32.5 | -42,555 | -6.44% | ✓ | $84.9K |
| Mar 12, 2024 | Mar 14, 2024 | Moore Carol | SVP Reg. & Quality | Sell | 41.3 | -20,619 | -4.03% | ✓ | $41.6K |
| Mar 12, 2024 | Mar 14, 2024 | Jensen Chrystal | Chief Legal Officer | Sell | 32.5 | -35,284 | -6.71% | ✓ | $71.1K |
| Mar 12, 2024 | Mar 14, 2024 | Jayaraman Vivek K | COO | Sell | 32.5 | -53,041 | -5.69% | ✓ | $106.9K |
| Mar 12, 2024 | Mar 14, 2024 | Greenman William Mariner | CEO | Sell | 35.0 | -125,926 | -3.81% | ✓ | $256.4K |
| Mar 12, 2024 | Mar 14, 2024 | CORASH LAURENCE M | Chief Scientific Officer | Sell | 45.0 | -28,427 | -1.20% | ✓ | $57.3K |
| Mar 12, 2024 | Mar 14, 2024 | Benjamin Richard J | Chief Medical Officer | Sell | 32.5 | -35,115 | -7.10% | ✓ | $70.8K |
| Mar 8, 2024 | Mar 12, 2024 | Benjamin Richard J | Chief Medical Officer | Sell | 32.5 | -29,378 | -5.79% | ✓ | $70.5K |
| Mar 1, 2024 | Mar 5, 2024 | Moore Carol | SVP Reg. & Quality | Neutral | 90.0 | +75,000 | 17.66% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | Menard Chrystal | Chief Legal Officer | Neutral | 90.0 | +160,000 | 45.78% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | Jayaraman Vivek K | COO | Neutral | 90.0 | +240,000 | 36.00% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | Greenman William Mariner | CEO | Neutral | 90.0 | +575,000 | 21.56% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | Green Kevin Dennis | CFO | Neutral | 90.0 | +200,000 | 45.49% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | CORASH LAURENCE M | Chief Scientific Officer | Neutral | 82.5 | +90,000 | 3.98% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | Benjamin Richard J | Chief Medical Officer | Neutral | 90.0 | +160,000 | 46.05% | ✗ | - |
| Dec 13, 2023 | Dec 13, 2023 | BJERKHOLT ERIC | Director | Buy | 86.3 | +10,000 | 7.57% | ✗ | $16.2K |
| Aug 22, 2023 | Aug 23, 2023 | Lucena Ann | Director | Buy | 91.3 | +7,500 | 11.58% | ✗ | $12.6K |
| Aug 21, 2023 | Aug 23, 2023 | BJERKHOLT ERIC | Director | Buy | 86.3 | +10,000 | 8.19% | ✗ | $17.2K |
| Jun 7, 2023 | Jun 9, 2023 | Witney Frank | Director | Neutral | 90.0 | +40,000 | 33.32% | ✗ | - |
| Jun 7, 2023 | Jun 9, 2023 | Swisher Daniel N JR | Director | Neutral | 90.0 | +40,000 | 61.97% | ✗ | - |
| Jun 7, 2023 | Jun 9, 2023 | SCHULZE GAIL | Director | Neutral | 90.0 | +40,000 | 47.95% | ✗ | - |
| Jun 7, 2023 | Jun 9, 2023 | NACHTSHEIM JAMI K | Director | Neutral | 90.0 | +40,000 | 60.28% | ✗ | - |
| Jun 7, 2023 | Jun 9, 2023 | MOORE TIMOTHY L. | Director | Neutral | 90.0 | +40,000 | 61.47% | ✗ | - |
| Jun 7, 2023 | Jun 9, 2023 | Lucena Ann | Director | Neutral | 90.0 | +40,000 | 161.39% | ✗ | - |
| Jun 7, 2023 | Jun 9, 2023 | BJERKHOLT ERIC | Director | Neutral | 90.0 | +40,000 | 48.70% | ✗ | - |
| May 26, 2023 | May 30, 2023 | Swisher Daniel N JR | Director | Buy | 82.5 | +5,000 | 4.39% | ✗ | $9.5K |
| May 24, 2023 | May 24, 2023 | SCHULZE GAIL | Director | Buy | 91.3 | +9,850 | 13.39% | ✗ | $20K |
| May 23, 2023 | May 23, 2023 | BJERKHOLT ERIC | Director | Buy | 86.3 | +5,000 | 6.48% | ✗ | $10K |
| Mar 12, 2023 | Mar 14, 2023 | Moore Carol | SVP Reg. & Quality | Sell | 48.8 | -13,078 | -1.56% | ✓ | $36.6K |
| Mar 12, 2023 | Mar 14, 2023 | Jayaraman Vivek K | COO | Sell | 45.0 | -25,356 | -1.91% | ✓ | $71K |
| Mar 12, 2023 | Mar 14, 2023 | Menard Chrystal | Chief Legal Officer | Sell | 45.0 | -15,468 | -2.20% | ✓ | $43.3K |
| Mar 12, 2023 | Mar 14, 2023 | Greenman William Mariner | CEO | Sell | 42.5 | -60,480 | -1.13% | ✗ | $169.3K |
| Mar 12, 2023 | Mar 14, 2023 | Green Kevin Dennis | CFO | Sell | 48.8 | -17,163 | -1.96% | ✓ | $48.1K |
| Mar 12, 2023 | Mar 14, 2023 | CORASH LAURENCE M | Chief Scientific Officer | Sell | 52.5 | -15,342 | -0.34% | ✓ | $43K |
| Mar 12, 2023 | Mar 14, 2023 | Benjamin Richard J | Chief Medical Officer | Sell | 41.3 | -25,353 | -2.35% | ✓ | $70.8K |
| Mar 1, 2023 | Mar 3, 2023 | Moore Carol | SVP Reg. & Quality | Neutral | 90.0 | +110,000 | 38.75% | ✗ | - |
| Mar 1, 2023 | Mar 3, 2023 | Menard Chrystal | Chief Legal Officer | Neutral | 90.0 | +160,000 | 97.05% | ✗ | - |
| Mar 1, 2023 | Mar 3, 2023 | Jayaraman Vivek K | COO | Neutral | 90.0 | +240,000 | 64.13% | ✗ | - |
| Mar 1, 2023 | Mar 3, 2023 | Greenman William Mariner | CEO | Neutral | 90.0 | +575,000 | 29.16% | ✗ | - |
| Mar 1, 2023 | Mar 3, 2023 | Green Kevin Dennis | CFO | Neutral | 90.0 | +185,000 | 82.96% | ✗ | - |
| Mar 1, 2023 | Mar 3, 2023 | CORASH LAURENCE M | Chief Scientific Officer | Neutral | 85.0 | +110,000 | 5.17% | ✗ | - |
| Mar 1, 2023 | Mar 3, 2023 | Benjamin Richard J | Chief Medical Officer | Neutral | 90.0 | +160,000 | 92.66% | ✗ | - |
| Dec 28, 2022 | Jan 3, 2023 | SCHULZE GAIL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 28, 2021 | Dec 30, 2022 | SCHULZE GAIL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 10, 2022 | Nov 14, 2022 | Swisher Daniel N JR | Director | Sell | 26.3 | -12,500 | -9.90% | ✗ | $48.9K |
| Aug 15, 2022 | Aug 17, 2022 | Menard Chrystal | Chief Legal Officer | Sell | 32.5 | -10,000 | -5.72% | ✓ | $51.8K |